Sicca Symptoms in Parkinson’s Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life
Table 1
Demographic and clinical characteristics (n = 93).
Age (mean, SD; years)
66.9
10.1
Disease duration (mean, SD; months)
116.13
81.0
Sex (no., %)
Female
34
36.6
Male
59
63.4
Hoehn and Yahr (median, IQR)
3.0
2
Survey of autonomic symptoms subscore A(mean, SD)
3.3
1.9
Survey of autonomic symptoms total score (mean, SD)
10.5
6.7
MDS-UPDRS III (mean, SD)
31.4
13.9
NMS-Quest (mean, SD)
10.6
4.7
Levodopa equivalent daily dose (mean, SD, mg)
773
695
Health-related QoL (mean, SD)
(i) PDQ-39 mobility
50.9
29.0
(ii) PDQ-39 activities of daily living
39.2
26.6
(iii) PDQ-39 emotional well-being
34.5
24.5
(iv) PDQ-39 stigmatisation
19.0
23.3
(v) PDQ-39 social support
15.5
18.4
(vi) PDQ-39 cognition
34.4
21.7
(vii) PDQ-39 communication
26.1
21.9
(viii) PDQ-39 bodily discomfort
36.7
25.9
(ix) PDQ-39 summary index
31.9
16.9
Abbreviations. MDS-UPDRS, Movement Disorder Society-sponsored revision of the unified Parkinson’s Disease Rating Scale; NMS-Quest, revised nonmotor symptoms questionnaire; PDQ-39, Parkinson’s disease quality of life questionnaire.
